<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03410147</url>
  </required_header>
  <id_info>
    <org_study_id>S61107</org_study_id>
    <nct_id>NCT03410147</nct_id>
  </id_info>
  <brief_title>A Dose-finding and Feasibility Study for a Prolonged 13C-octanoate Breath Test for Gastric Emptying</brief_title>
  <acronym>ANTERO-AC-7</acronym>
  <official_title>A Dose-finding and Feasibility Study for a Prolonged 13C-octanoate Breath Test for Gastric Emptying During Continuous Nutrient Infusion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this dose-finding and feasibility study is to establish the optimal
      13C-octanoate concentration to be used with slowly infused enteral nutrition to perform a
      prolonged gastric emptying test using the breath test. More specifically, the aim is to
      discover the 13C-octanoate concentration that induces a steady state hourly 13C-recovery.
      This would allow to implement the prolonged breath test protocol in a future clinical
      investigation in critically ill patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 9, 2018</start_date>
  <completion_date type="Anticipated">June 22, 2018</completion_date>
  <primary_completion_date type="Anticipated">June 22, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>A single blind, randomized, crossover monocentric study in a cohort of adult healthy volunteers</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hourly 13C-recovery</measure>
    <time_frame>8 hour</time_frame>
    <description>Indicator for gastric emptying rate</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">8</enrollment>
  <condition>Healthy</condition>
  <condition>Gastric Emptying</condition>
  <arm_group>
    <arm_group_label>Concentration A</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Concentration of 13C-sodium octanoate in enteral nutrition is 0.3 mg/ml</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Concentration B</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Concentration of 13C-sodium octanoate in enteral nutrition is 1.0 mg/ml</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Concentration C</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Concentration of 13C-sodium octanoate in enteral nutrition is 3.0 mg/ml</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>13C-octanoate breath test for gastric emptying</intervention_name>
    <description>The 13C-octanoate breath test for gastric emptying will be performed to assess gastric emptying rate of a liquid meal that is infused continuously over a period of 8 hour.
13C-labeled sodium octanoate (food adjective) is mixed with liquid nutrients used for enteral feeding. The concentration of 13C-labeled sodium octanoate is according to the randomized treatment order. This mixture is infused at 20 ml/h for 8 hours (hourly dose of 13C-octanoate differs between treatment arms). In order to estimate gastric emptying rate quantitatively throughout the infusion period, the appearance of 13CO2 in the breath, relative to 12CO2, will be monitored by sampling the exhaled breath at a 15 minute interval.
The aim is to induce a steady state hourly 13C-recovery. This would allow to implement the prolonged breath test protocol in future clinical investigations.</description>
    <arm_group_label>Concentration A</arm_group_label>
    <arm_group_label>Concentration B</arm_group_label>
    <arm_group_label>Concentration C</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Signed Informed Consent

          -  At least 18 years old

          -  BMI between and including 18 and 29

          -  Understand and able to read Dutch

          -  In good health on the basis of medical history

          -  Refrains from herbal, vitamin and other dietary supplements on the day of the visits

        Exclusion Criteria:

          -  Dyspeptic symptoms (assessed with PAGI-SYM questionnaire, Annex II)

          -  Using any medication that might affect gastric function or visceral sensitivity

          -  Known / suspected current use of illicit drugs

          -  Known psychiatric or neurological illness

          -  Any gastrointestinal surgery that could influence normal gastric function in the
             opinion of the investigator

          -  History of heart or vascular diseases like irregular heartbeats, angina or heart
             attack

          -  Nasopharyngeal surgery in the last 30 days

          -  Suspected basal skull fracture or severe maxillofacial trauma

          -  History of thermal or chemical injury to upper respiratory tract or esophagus

          -  Current esophageal or nasopharyngeal obstruction

          -  Known coagulopathy

          -  Known esophageal varices

          -  Have a known allergy or intolerance to cow milk, soy or any other ingredient of
             Isosource Standard.

          -  Known galactosaemia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Nick Goelen, MSc</last_name>
    <phone>+32 16 372342</phone>
    <email>nick.goelen@kuleuven.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>UZ Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pieter Janssen, PhD</last_name>
      <phone>+32474964526</phone>
      <email>pieter.janssen@kuleuven.be</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 18, 2018</study_first_submitted>
  <study_first_submitted_qc>January 18, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 25, 2018</study_first_posted>
  <last_update_submitted>February 9, 2018</last_update_submitted>
  <last_update_submitted_qc>February 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitaire Ziekenhuizen Leuven</investigator_affiliation>
    <investigator_full_name>Prof Dr Jan Tack</investigator_full_name>
    <investigator_title>prof. dr.</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

